Skip to content

Clover Health Investments CLOV Additional Paid-In Capital

Additional Paid-In Capital at other companies

Humana logo
HumanaHUM
$3.64B+4.1%
UnitedHealth Group logo
UnitedHealth GroupUNH
$556M
Alignment Healthcare logo
Alignment HealthcareALHC
$1.2B+7.0%
Astrana Health logo
Astrana HealthASTH
$477.51M+5.5%
Agilon Health logo
Agilon HealthAGL
$2.11B+1.9%
Elevance Health logo
Elevance HealthELV
$8.85B-0.2%

Other financials

Income statement

See full
Revenue$749.2M+62.0%
Operating income$27.3M+2,246%
Net income$27.3M+2,246%
EPS (diluted)$0.05

Balance sheet

See full
Cash & equivalents$173.3M+11.5%
Total debt$3.3M-0.9%
Total equity$339.4M+1.0%
Total assets$697.7M+19.5%

Cash flow

See full
Operating cash flow$107.9M+762%
CapEx$854.0K+362%
Free cash flow$107.0M+750%

Valuation

See full
Market cap$2.67B-49.7%
P/S1.2×-2.4×

Profitability

See full
Operating margin-2.6%+3.5pp
Net margin-2.6%+2.8pp
FCF margin-10.3%

Returns & leverage

See full
Return on equity-16.9%-170pp
Debt / equity0.0×
Current ratio1.3×-0.2×

Where this comes from

Reported directly by Clover Health Investments in its filing.

Tagged under the XBRL concept us-gaap:AdditionalPaidInCapital.

The official record: Clover Health Investments’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Clover Health Investments's additional paid-in capital.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Clover Health Investments's additional paid-in capital?
Clover Health Investments (CLOV) reported additional paid-in capital of $2.7B in Q1 2026.
How has Clover Health Investments's additional paid-in capital changed year-over-year?
Clover Health Investments's additional paid-in capital increased by 3.5% year-over-year, from $2.6B to $2.7B.
What is the long-term trend for Clover Health Investments's additional paid-in capital?
Over 5 years (2020 to 2025), Clover Health Investments's additional paid-in capital has grown at a 45.5% compound annual growth rate (CAGR), from $411.87M to $2.68B.
What does additional paid-in capital mean?
Capital received from shareholders in excess of par value — the premium investors paid over the nominal value of shares at issuance, plus stock-based compensation effects.